Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Perry

Showing results (401-410 of 628) with videos related to

Pageof 63
Sort By:
Current Neurovascular Research|September 27, 2005
A second look into the oxidant mechanisms in Alzheimer's diseasePaula I Moreira, Catarina R Oliveira, Maria S Santos, et al.
The Journal of Biological Chemistry|May 29, 2008
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studiesRobert P Friedland, Johnathan M Tedesco, Andrea C Wilson, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Therapeutic Trials in Alzheimer's Disease: Where Are We Now?Paula I Moreira, Jesus Avila, Daniela Galimberti, et al.
International Journal of Molecular Sciences|April 13, 2024
Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?Poul F Høilund-Carlsen, Abass Alavi, Rudolph J Castellani, et al.
International Journal of Circumpolar Health|May 11, 2002
Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicityKimberly L Clapp-Lilly, Mark A Smith, George Perry, et al.
Aging Cell|May 28, 2011
DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's diseaseXinglong Wang, Bo Su, Wanhong Liu, et al.
Age (Dordrecht, Netherlands)|April 20, 2013
Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathyMark A Smith, Xiongwei Zhu, Hyoung-Gon Lee, et al.
Expert Review of Neurotherapeutics|July 1, 2010
Antioxidant approaches for the treatment of Alzheimer's diseaseHyun Pil Lee, Xiongwei Zhu, Gemma Casadesus, et al.
Biochimica Et Biophysica Acta|October 27, 2009
Mitochondria: a therapeutic target in neurodegenerationPaula I Moreira, Xiongwei Zhu, Xinglong Wang, et al.
Expert Review of Neurotherapeutics|November 12, 2009
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's diseaseHyun-Pil Lee, Gemma Casadesus, Xiongwei Zhu, et al.
Pageof 63

Showing results (401-410 of 628) with videos related to

Sort By:
Pageof 63
Current Neurovascular Research|September 27, 2005
A second look into the oxidant mechanisms in Alzheimer's diseasePaula I Moreira, Catarina R Oliveira, Maria S Santos, et al.
The Journal of Biological Chemistry|May 29, 2008
Antibodies to potato virus Y bind the amyloid beta peptide: immunohistochemical and NMR studiesRobert P Friedland, Johnathan M Tedesco, Andrea C Wilson, et al.
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Therapeutic Trials in Alzheimer's Disease: Where Are We Now?Paula I Moreira, Jesus Avila, Daniela Galimberti, et al.
International Journal of Molecular Sciences|April 13, 2024
Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?Poul F Høilund-Carlsen, Abass Alavi, Rudolph J Castellani, et al.
International Journal of Circumpolar Health|May 11, 2002
Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicityKimberly L Clapp-Lilly, Mark A Smith, George Perry, et al.
Aging Cell|May 28, 2011
DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's diseaseXinglong Wang, Bo Su, Wanhong Liu, et al.
Age (Dordrecht, Netherlands)|April 20, 2013
Sequestration of p27 within the cytoplasm of cardiac myocytes in chronic ischemic heart disease: pathogenic implications for ischemic cardiomyopathyMark A Smith, Xiongwei Zhu, Hyoung-Gon Lee, et al.
Expert Review of Neurotherapeutics|July 1, 2010
Antioxidant approaches for the treatment of Alzheimer's diseaseHyun Pil Lee, Xiongwei Zhu, Gemma Casadesus, et al.
Biochimica Et Biophysica Acta|October 27, 2009
Mitochondria: a therapeutic target in neurodegenerationPaula I Moreira, Xiongwei Zhu, Xinglong Wang, et al.
Expert Review of Neurotherapeutics|November 12, 2009
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's diseaseHyun-Pil Lee, Gemma Casadesus, Xiongwei Zhu, et al.
Pageof 63